USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name: CALISTA THERAPEUTICS, INC.
City: LINCOLN
State: RI
Zip+4: 02865-1511
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Website URL: N/A
Phone: (401) 345-5979

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $224,993.00 1

Award List:

An Automated Platform for High-throughput Network Electrophysiology

Award Year / Program / Phase: 2013 / SBIR / Phase I
Agency: HHS
Principal Investigator: Alvin Bach – 401-345-5979
Award Amount: $224,993.00
Abstract:
DESCRIPTION (provided by applicant): Calista Therapeutics has discovered a first-in-class, proprietary PDZ1-2 lead drug, AT010, that is being optimized and developed as an inhaled daily therapy for cystic fibrosis (CF). CF is a deadly inherited genetic disorder that disrupts chloride channel… More